anti-SARS-CoV-2 antibodies (Fusion Antibodies/Queen's University Belfast)
N/A
Report date: 2025/01/26 19:31:46
Base Information
Drug Nameanti-SARS-CoV-2 antibodies (Fusion Antibodies/Queen's University Belfast)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFusion Antibodies
China Registration ClassN/A
Develop Information
Active CompaniesQueens University of BelfastFusion Antibodies
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A